
PMC:7317273 / 427-691
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 80-102 | Body_part | denotes | Mesenchymal Stem Cells | http://purl.org/sig/ont/fma/fma0326143 |
T4 | 97-102 | Body_part | denotes | Cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 80-102 | http://purl.obolibrary.org/obo/CL_0000134 | denotes | Mesenchymal Stem Cells |
T6 | 113-114 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 10-170 | Sentence | denotes | As no effective treatment is currently available, we propose ‘Primed’ Mesenchymal Stem Cells (MSCs) as a therapeutic alternative to tackle devastating epidemic. |
T6 | 171-230 | Sentence | denotes | The individual response to MSCs treatment is heterogeneous. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 80-91 | CL:0000134;UBERON:0003104 | denotes | Mesenchymal |
T7 | 92-102 | CL:0000034 | denotes | Stem Cells |
T8 | 104-108 | DG_47 | denotes | MSCs |
T9 | 198-202 | DG_47 | denotes | MSCs |
T65742 | 80-91 | CL:0000134;UBERON:0003104 | denotes | Mesenchymal |
T84391 | 92-102 | CL:0000034 | denotes | Stem Cells |
T67622 | 104-108 | DG_47 | denotes | MSCs |
T8999 | 198-202 | DG_47 | denotes | MSCs |